Relative contributions of the components of the American College of Rheumatology 20% criteria for improvement to responder status in patients with early seropositive rheumatoid arthritis
Open Access
- 1 December 2000
- journal article
- basic science
- Published by Wiley in Arthritis & Rheumatism
- Vol. 43 (12) , 2743-2750
- https://doi.org/10.1002/1529-0131(200012)43:12<2743::aid-anr14>3.0.co;2-a
Abstract
Objective To evaluate factors that influence the responses defined by the American College of Rheumatology (ACR) 20% criteria for improvement in rheumatoid arthritis (RA). Methods ACR 20% and 50% response rates were calculated from data collected for the intervals 0–6, 0–12, and 0–24 months for 180 RA patients participating in the Western Consortium of Practicing Rheumatologists long‐term observational study of early seropositive RA (mean ± SD duration of RA at study entry 6.0 ± 3.4 months). Analyzable cases were patients with paired data for tender and swollen joint counts plus at least 3 of the following criteria: physician's and patient's global assessments of disease activity and patient's score for pain (by visual analog scale), physical function score on the Health Assessment Questionnaire (HAQ), and levels of an acute‐phase reactant. Response rates were then recalculated by 3 different methods: 1) using only cases with complete paired data for all criteria, 2) sequentially assuming no improvement in each of the 5 secondary criteria, and 3) substituting grip strength for HAQ scores. Results Using 464 paired observations for all analyzable cases, ACR 20% (50%) improvement rates were 52.6% (33.0%), compared with 55.6% (34.8%) for 365 paired observations from the cases with complete data. Decreases in ACR response rates when secondary criteria were sequentially set at “no improvement” ranged from 11.7% (pain at 0–6 months) to 1.2% (C‐reactive protein at 0–12 months), but these were not statistically different by the kappa statistic. Overall numerical rankings of the relative contributions of the secondary criteria to the ACR 20% or 50% response rates were physician's global assessment, pain, HAQ, patient's global assessment, and acute‐phase reactant. Only 7.8% of paired grip strength observations showed ≥20% improvement, compared with 71% of paired HAQ observations. Conclusion The use of all “analyzable” cases (paired data for tender and swollen joint counts plus ≥3 of the 5 secondary criteria) increases the number of subjects and only slightly decreases the ACR response rate compared with analyses limited to cases with complete data. The contributions of the secondary criteria are not statistically different, supporting their equal weighting in the ACR definition of improvement. The ACR 20% response rates are higher when the HAQ, rather than grip strength, is used to measure physical function.Keywords
This publication has 9 references indexed in Scilit:
- Lack of efficacy of oral bovine type II collagen added to existing therapy in rheumatoid arthritisArthritis & Rheumatism, 1999
- Should imporvement in rheumatoid arthritis clinical trials be defined as fifty percent or seventy percent improvement in core set measures, rather than twenty percent?Arthritis & Rheumatism, 1998
- Should imporvement in rheumatoid arthritis clinical trials be defined as fifty percent or seventy percent improvement in core set measures, rather than twenty percent?Arthritis & Rheumatism, 1998
- American college of rheumatology preliminary definition of improvement in rheumatoid arthritisArthritis & Rheumatism, 1995
- Serum concentrations of 10 acute-phase proteins in healthy term and preterm infants from birth to age 6 monthsClinical Chemistry, 1995
- The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trialsArthritis & Rheumatism, 1993
- Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis.Annals of the Rheumatic Diseases, 1992
- Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score.Annals of the Rheumatic Diseases, 1990
- Recommendation for a selected method for the measurement of plasma viscosity. International Committee for Standardization in Haematology.Journal of Clinical Pathology, 1984